Share Price and Basic Stock Data
Last Updated: February 14, 2026, 8:40 pm
| PEG Ratio | -1.52 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Finolex Industries Ltd operates in the plastics sector, primarily focusing on pipes and fittings. As of the latest market data, the company’s stock price stood at ₹179 with a market capitalization of ₹11,105 Cr. The company recorded sales of ₹4,397 Cr for the fiscal year ending March 2023, a decline from ₹4,647 Cr in the previous year. However, trailing twelve months (TTM) revenue is reported at ₹4,075 Cr, indicating a slight decrease in overall performance. Quarterly sales data shows fluctuations, with the highest sales of ₹1,179 Cr recorded in June 2023, followed by a drop to ₹883 Cr in September 2023. This volatility signifies challenges in maintaining consistent revenue streams, potentially influenced by market demand and competitive pressures in the plastics industry.
Profitability and Efficiency Metrics
Finolex Industries reported a net profit of ₹237 Cr for the fiscal year ending March 2023, a significant decline from ₹1,053 Cr in the previous year. The operating profit margin (OPM) for the same period stood at 7%, a sharp decrease from 22% in March 2022. This downturn reflects rising operational costs affecting profitability. The company’s return on equity (ROE) was recorded at 6.76%, which is relatively low compared to typical sector benchmarks, indicating suboptimal utilization of equity. The interest coverage ratio (ICR) of 24.37x highlights strong debt servicing capacity, suggesting that while profitability may be under pressure, financial obligations are well managed. Additionally, the cash conversion cycle (CCC) of 80 days signals efficiency in managing working capital, although improvements may be necessary to enhance liquidity.
Balance Sheet Strength and Financial Ratios
Finolex Industries’ financial stability is underscored by total reserves of ₹5,666 Cr and minimal borrowings of ₹21 Cr, leading to a debt-to-equity ratio of just 0.03x, significantly lower than industry averages. This conservative leverage positions the company favorably against financial stress. The company’s current ratio of 3.56x indicates robust liquidity, suggesting that it can comfortably cover short-term liabilities. However, the price-to-book value (P/BV) ratio is recorded at 1.83x, reflecting a moderate valuation relative to its book value. The return on capital employed (ROCE) was reported at 9%, which is below optimal levels, indicating that capital is not being effectively utilized to generate profit. Overall, the balance sheet reflects significant strength, but the efficiency ratios suggest areas for improvement.
Shareholding Pattern and Investor Confidence
Finolex Industries maintains a stable shareholding structure, with promoters holding 52.47% of the equity, showcasing strong control and commitment. Foreign institutional investors (FIIs) account for 5.93%, while domestic institutional investors (DIIs) hold 12.11%, reflecting a balanced institutional interest. The public stake is recorded at 29.13%, indicating a healthy retail investor base. Over the past few quarters, the number of shareholders has fluctuated, with 2,45,505 recorded in September 2025, down from 2,48,095 in December 2022. This slight decline may raise concerns regarding investor sentiment. The company’s dividend payout ratio of 19.32% for the fiscal year 2025 demonstrates a commitment to returning value to shareholders, which may help sustain investor confidence amidst profitability challenges.
Outlook, Risks, and Final Insight
The outlook for Finolex Industries hinges on its ability to stabilize revenue and improve profitability amidst a competitive landscape. Key strengths include a robust balance sheet with low debt levels and strong liquidity, which provides a buffer against economic fluctuations. However, the company faces risks such as declining profitability and fluctuating sales, which could impact investor sentiment. Additionally, rising operational costs and market competition present ongoing challenges. To enhance growth prospects, the company may need to focus on operational efficiencies and strategic market positioning. With improved execution, Finolex could potentially leverage its strong balance sheet to invest in growth opportunities, thereby enhancing shareholder value in the long term.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Finolex Industries Ltd | 11,710 Cr. | 189 | 238/144 | 24.6 | 93.3 | 1.06 % | 8.77 % | 6.76 % | 2.00 |
| Industry Average | 11,710.00 Cr | 189.00 | 24.60 | 93.30 | 1.06% | 8.77% | 6.76% | 2.00 |
Quarterly Result
| Metric | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,125 | 1,141 | 1,179 | 883 | 1,020 | 1,235 | 1,140 | 828 | 1,001 | 1,172 | 1,043 | 859 | 898 |
| Expenses | 1,033 | 924 | 1,027 | 780 | 900 | 1,026 | 934 | 818 | 918 | 1,001 | 950 | 729 | 775 |
| Operating Profit | 92 | 217 | 152 | 103 | 120 | 209 | 207 | 11 | 83 | 171 | 94 | 130 | 123 |
| OPM % | 8% | 19% | 13% | 12% | 12% | 17% | 18% | 1% | 8% | 15% | 9% | 15% | 14% |
| Other Income | 28 | 29 | 40 | 63 | 35 | 44 | 472 | 84 | 48 | 65 | 65 | 60 | 52 |
| Interest | 5 | 6 | 9 | 12 | 8 | 7 | 7 | 7 | 10 | 6 | 6 | 4 | 3 |
| Depreciation | 22 | 24 | 34 | 27 | 28 | 27 | 26 | 26 | 27 | 27 | 27 | 27 | 26 |
| Profit before tax | 92 | 216 | 149 | 126 | 120 | 219 | 646 | 62 | 95 | 203 | 126 | 158 | 146 |
| Tax % | 22% | 27% | 26% | 25% | 26% | 26% | 22% | 16% | 25% | 26% | 23% | 25% | 25% |
| Net Profit | 72 | 158 | 111 | 94 | 89 | 161 | 505 | 51 | 71 | 150 | 97 | 119 | 110 |
| EPS in Rs | 1.16 | 2.55 | 1.79 | 1.51 | 1.44 | 2.60 | 8.14 | 0.83 | 1.14 | 2.42 | 1.56 | 1.92 | 1.77 |
Last Updated: February 5, 2026, 11:46 pm
Below is a detailed analysis of the quarterly data for Finolex Industries Ltd based on the most recent figures (Dec 2025) and their trends compared to the previous period:
- For Sales, as of Dec 2025, the value is 898.00 Cr.. The value appears strong and on an upward trend. It has increased from 859.00 Cr. (Sep 2025) to 898.00 Cr., marking an increase of 39.00 Cr..
- For Expenses, as of Dec 2025, the value is 775.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 729.00 Cr. (Sep 2025) to 775.00 Cr., marking an increase of 46.00 Cr..
- For Operating Profit, as of Dec 2025, the value is 123.00 Cr.. The value appears to be declining and may need further review. It has decreased from 130.00 Cr. (Sep 2025) to 123.00 Cr., marking a decrease of 7.00 Cr..
- For OPM %, as of Dec 2025, the value is 14.00%. The value appears to be declining and may need further review. It has decreased from 15.00% (Sep 2025) to 14.00%, marking a decrease of 1.00%.
- For Other Income, as of Dec 2025, the value is 52.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Sep 2025) to 52.00 Cr., marking a decrease of 8.00 Cr..
- For Interest, as of Dec 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 4.00 Cr. (Sep 2025) to 3.00 Cr., marking a decrease of 1.00 Cr..
- For Depreciation, as of Dec 2025, the value is 26.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 27.00 Cr. (Sep 2025) to 26.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Dec 2025, the value is 146.00 Cr.. The value appears to be declining and may need further review. It has decreased from 158.00 Cr. (Sep 2025) to 146.00 Cr., marking a decrease of 12.00 Cr..
- For Tax %, as of Dec 2025, the value is 25.00%. The value remains steady. There is no change compared to the previous period (Sep 2025) which recorded 25.00%.
- For Net Profit, as of Dec 2025, the value is 110.00 Cr.. The value appears to be declining and may need further review. It has decreased from 119.00 Cr. (Sep 2025) to 110.00 Cr., marking a decrease of 9.00 Cr..
- For EPS in Rs, as of Dec 2025, the value is 1.77. The value appears to be declining and may need further review. It has decreased from 1.92 (Sep 2025) to 1.77, marking a decrease of 0.15.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:22 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 2,453 | 2,476 | 2,482 | 2,602 | 2,738 | 3,091 | 2,985 | 3,462 | 4,647 | 4,397 | 4,317 | 4,142 | 4,075 |
| Expenses | 2,056 | 2,264 | 2,075 | 2,039 | 2,253 | 2,487 | 2,536 | 2,472 | 3,623 | 4,105 | 3,732 | 3,666 | 3,596 |
| Operating Profit | 397 | 212 | 407 | 563 | 484 | 604 | 448 | 990 | 1,025 | 293 | 585 | 476 | 478 |
| OPM % | 16% | 9% | 16% | 22% | 18% | 20% | 15% | 29% | 22% | 7% | 14% | 12% | 12% |
| Other Income | -27 | -2 | 62 | 24 | 25 | 14 | 30 | 72 | 458 | 121 | 181 | 665 | 237 |
| Interest | 66 | 70 | 45 | 15 | 10 | 12 | 11 | 7 | 14 | 27 | 36 | 30 | 26 |
| Depreciation | 62 | 59 | 51 | 55 | 61 | 70 | 74 | 78 | 83 | 89 | 116 | 107 | 108 |
| Profit before tax | 242 | 81 | 373 | 517 | 439 | 536 | 393 | 977 | 1,385 | 297 | 613 | 1,005 | 581 |
| Tax % | 30% | 41% | 32% | 32% | 32% | 35% | 18% | 25% | 24% | 20% | 26% | 23% | |
| Net Profit | 170 | 48 | 254 | 352 | 299 | 350 | 324 | 728 | 1,053 | 237 | 455 | 778 | 437 |
| EPS in Rs | 2.74 | 0.77 | 4.10 | 5.68 | 4.81 | 5.64 | 5.22 | 11.73 | 16.98 | 3.81 | 7.34 | 12.54 | 7.04 |
| Dividend Payout % | 51% | 52% | 49% | 41% | 42% | 35% | 38% | 34% | 24% | 39% | 34% | 29% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -71.76% | 429.17% | 38.58% | -15.06% | 17.06% | -7.43% | 124.69% | 44.64% | -77.49% | 91.98% | 70.99% |
| Change in YoY Net Profit Growth (%) | 0.00% | 500.93% | -390.58% | -53.64% | 32.11% | -24.49% | 132.12% | -80.05% | -122.14% | 169.48% | -20.99% |
Finolex Industries Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 7% |
| 3 Years: | -4% |
| TTM: | -5% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 4% |
| 3 Years: | -20% |
| TTM: | -29% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 16% |
| 5 Years: | 16% |
| 3 Years: | 12% |
| 1 Year: | -29% |
| Return on Equity | |
|---|---|
| 10 Years: | 13% |
| 5 Years: | 12% |
| 3 Years: | 7% |
| Last Year: | 7% |
Last Updated: September 5, 2025, 4:10 am
Balance Sheet
Last Updated: December 4, 2025, 1:15 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 | 124 |
| Reserves | 666 | 663 | 1,446 | 2,167 | 2,640 | 2,404 | 1,806 | 2,949 | 3,740 | 4,701 | 5,414 | 5,855 | 5,666 |
| Borrowings | 713 | 637 | 212 | 94 | 101 | 90 | 283 | 204 | 278 | 541 | 394 | 237 | 21 |
| Other Liabilities | 433 | 435 | 567 | 570 | 589 | 655 | 603 | 930 | 1,119 | 817 | 996 | 1,008 | 798 |
| Total Liabilities | 1,936 | 1,859 | 2,349 | 2,955 | 3,455 | 3,273 | 2,815 | 4,207 | 5,261 | 6,182 | 6,928 | 7,223 | 6,609 |
| Fixed Assets | 905 | 868 | 850 | 855 | 884 | 951 | 1,017 | 1,002 | 993 | 1,055 | 1,055 | 1,008 | 1,015 |
| CWIP | 32 | 10 | 7 | 22 | 90 | 90 | 7 | 8 | 9 | 44 | 19 | 73 | 41 |
| Investments | 221 | 180 | 817 | 1,222 | 1,555 | 1,303 | 580 | 1,592 | 2,633 | 3,850 | 4,456 | 4,751 | 4,239 |
| Other Assets | 777 | 801 | 675 | 856 | 925 | 929 | 1,211 | 1,604 | 1,625 | 1,234 | 1,398 | 1,391 | 1,314 |
| Total Assets | 1,936 | 1,859 | 2,349 | 2,955 | 3,455 | 3,273 | 2,815 | 4,207 | 5,261 | 6,182 | 6,928 | 7,223 | 6,609 |
Below is a detailed analysis of the balance sheet data for Finolex Industries Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 124.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 124.00 Cr..
- For Reserves, as of Sep 2025, the value is 5,666.00 Cr.. The value appears to be declining and may need further review. It has decreased from 5,855.00 Cr. (Mar 2025) to 5,666.00 Cr., marking a decrease of 189.00 Cr..
- For Borrowings, as of Sep 2025, the value is 21.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 237.00 Cr. (Mar 2025) to 21.00 Cr., marking a decrease of 216.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 798.00 Cr.. The value appears to be improving (decreasing). It has decreased from 1,008.00 Cr. (Mar 2025) to 798.00 Cr., marking a decrease of 210.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 6,609.00 Cr.. The value appears to be improving (decreasing). It has decreased from 7,223.00 Cr. (Mar 2025) to 6,609.00 Cr., marking a decrease of 614.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 1,015.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,008.00 Cr. (Mar 2025) to 1,015.00 Cr., marking an increase of 7.00 Cr..
- For CWIP, as of Sep 2025, the value is 41.00 Cr.. The value appears to be declining and may need further review. It has decreased from 73.00 Cr. (Mar 2025) to 41.00 Cr., marking a decrease of 32.00 Cr..
- For Investments, as of Sep 2025, the value is 4,239.00 Cr.. The value appears to be declining and may need further review. It has decreased from 4,751.00 Cr. (Mar 2025) to 4,239.00 Cr., marking a decrease of 512.00 Cr..
- For Other Assets, as of Sep 2025, the value is 1,314.00 Cr.. The value appears to be declining and may need further review. It has decreased from 1,391.00 Cr. (Mar 2025) to 1,314.00 Cr., marking a decrease of 77.00 Cr..
- For Total Assets, as of Sep 2025, the value is 6,609.00 Cr.. The value appears to be declining and may need further review. It has decreased from 7,223.00 Cr. (Mar 2025) to 6,609.00 Cr., marking a decrease of 614.00 Cr..
Notably, the Reserves (5,666.00 Cr.) exceed the Borrowings (21.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -316.00 | -425.00 | 195.00 | 469.00 | 383.00 | 514.00 | 165.00 | 786.00 | -277.00 | -248.00 | 191.00 | 239.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 6 | 7 | 3 | 7 | 6 | 9 | 9 | 16 | 26 | 25 | 39 | 33 |
| Inventory Days | 112 | 113 | 100 | 128 | 128 | 120 | 164 | 176 | 132 | 81 | 99 | 108 |
| Days Payable | 25 | 40 | 55 | 52 | 52 | 55 | 44 | 84 | 60 | 35 | 39 | 61 |
| Cash Conversion Cycle | 93 | 80 | 48 | 83 | 81 | 74 | 129 | 108 | 98 | 71 | 98 | 80 |
| Working Capital Days | -14 | -6 | 0 | 28 | 32 | 33 | 39 | 22 | 17 | -6 | 13 | 20 |
| ROCE % | 23% | 11% | 24% | 25% | 17% | 21% | 16% | 36% | 27% | 6% | 10% | 9% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| SBI Small Cap Fund | 34,595,699 | 1.66 | 602 | 34,595,699 | 2025-04-22 14:12:25 | 0% |
| Franklin India Small Cap Fund | 7,057,734 | 0.93 | 122.81 | N/A | N/A | N/A |
| HSBC Small Cap Fund | 5,270,722 | 0.57 | 91.72 | 5,734,257 | 2026-01-26 03:05:13 | -8.08% |
| ICICI Prudential Smallcap Fund | 3,553,601 | 0.73 | 61.84 | 3,200,000 | 2026-01-26 08:54:41 | 11.05% |
| Bandhan Value Fund | 3,100,000 | 0.52 | 53.94 | 1,299,000 | 2026-01-26 07:39:09 | 138.65% |
| SBI Conservative Hybrid Fund | 2,476,176 | 0.44 | 43.09 | 2,476,176 | 2025-04-22 15:56:58 | 0% |
| HDFC Retirement Savings Fund - Equity | 1,650,000 | 0.41 | 28.71 | N/A | N/A | N/A |
| Bandhan Multi Cap Fund | 1,500,000 | 0.9 | 26.1 | 1,299,000 | 2025-12-15 01:03:40 | 15.47% |
| Templeton India Value Fund | 1,100,000 | 0.82 | 19.14 | N/A | N/A | N/A |
| ICICI Prudential Childrens Fund | 1,000,000 | 1.23 | 17.4 | N/A | N/A | N/A |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 2.00 | 2.00 | 2.00 | 2.00 | 10.00 |
| Basic EPS (Rs.) | 12.94 | 7.66 | 4.04 | 16.94 | 11.89 |
| Diluted EPS (Rs.) | 12.94 | 7.66 | 4.04 | 16.94 | 11.89 |
| Cash EPS (Rs.) | 14.01 | 8.92 | 5.10 | 18.31 | 64.41 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 98.60 | 91.12 | 79.29 | 63.30 | 252.94 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 98.60 | 91.12 | 79.29 | 63.30 | 252.94 |
| Revenue From Operations / Share (Rs.) | 66.98 | 69.82 | 71.11 | 74.90 | 279.03 |
| PBDIT / Share (Rs.) | 11.68 | 12.37 | 6.69 | 17.82 | 85.48 |
| PBIT / Share (Rs.) | 9.96 | 10.49 | 5.24 | 16.48 | 79.22 |
| PBT / Share (Rs.) | 16.22 | 9.90 | 4.80 | 22.31 | 78.64 |
| Net Profit / Share (Rs.) | 12.29 | 7.04 | 3.66 | 16.97 | 58.15 |
| NP After MI And SOA / Share (Rs.) | 12.94 | 7.66 | 4.05 | 16.94 | 59.45 |
| PBDIT Margin (%) | 17.44 | 17.71 | 9.40 | 23.79 | 30.63 |
| PBIT Margin (%) | 14.86 | 15.02 | 7.37 | 22.00 | 28.39 |
| PBT Margin (%) | 24.21 | 14.18 | 6.75 | 29.79 | 28.18 |
| Net Profit Margin (%) | 18.34 | 10.08 | 5.14 | 22.65 | 20.83 |
| NP After MI And SOA Margin (%) | 19.31 | 10.96 | 5.70 | 22.62 | 21.30 |
| Return on Networth / Equity (%) | 13.12 | 8.40 | 5.11 | 26.76 | 23.50 |
| Return on Capital Employeed (%) | 9.61 | 10.89 | 6.29 | 24.66 | 29.27 |
| Return On Assets (%) | 10.83 | 6.71 | 3.98 | 19.66 | 17.18 |
| Total Debt / Equity (X) | 0.03 | 0.06 | 0.10 | 0.07 | 0.06 |
| Asset Turnover Ratio (%) | 0.57 | 0.64 | 0.75 | 0.97 | 0.97 |
| Current Ratio (X) | 3.56 | 2.90 | 2.55 | 2.54 | 2.12 |
| Quick Ratio (X) | 2.75 | 2.24 | 1.95 | 1.69 | 1.14 |
| Inventory Turnover Ratio (X) | 5.48 | 3.92 | 3.44 | 2.90 | 2.18 |
| Dividend Payout Ratio (NP) (%) | 19.32 | 19.58 | 98.99 | 23.60 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 17.05 | 15.73 | 73.01 | 21.87 | 0.00 |
| Earning Retention Ratio (%) | 80.68 | 80.42 | 1.01 | 76.40 | 0.00 |
| Cash Earning Retention Ratio (%) | 82.95 | 84.27 | 26.99 | 78.13 | 0.00 |
| Interest Coverage Ratio (X) | 24.37 | 20.98 | 15.18 | 78.49 | 145.92 |
| Interest Coverage Ratio (Post Tax) (X) | 12.57 | 12.94 | 9.32 | 49.03 | 100.26 |
| Enterprise Value (Cr.) | 11222.93 | 15601.90 | 11024.14 | 9802.33 | 7772.76 |
| EV / Net Operating Revenue (X) | 2.71 | 3.61 | 2.51 | 2.11 | 2.24 |
| EV / EBITDA (X) | 15.53 | 20.40 | 26.66 | 8.86 | 7.33 |
| MarketCap / Net Operating Revenue (X) | 2.69 | 3.53 | 2.40 | 2.07 | 2.28 |
| Retention Ratios (%) | 80.67 | 80.41 | 1.00 | 76.39 | 0.00 |
| Price / BV (X) | 1.83 | 2.71 | 2.15 | 2.45 | 2.52 |
| Price / Net Operating Revenue (X) | 2.69 | 3.53 | 2.40 | 2.07 | 2.28 |
| EarningsYield | 0.07 | 0.03 | 0.02 | 0.10 | 0.09 |
After reviewing the key financial ratios for Finolex Industries Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 2.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 2.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For Diluted EPS (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For Cash EPS (Rs.), as of Mar 25, the value is 14.01. This value is within the healthy range. It has increased from 8.92 (Mar 24) to 14.01, marking an increase of 5.09.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.60. It has increased from 91.12 (Mar 24) to 98.60, marking an increase of 7.48.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 98.60. It has increased from 91.12 (Mar 24) to 98.60, marking an increase of 7.48.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 66.98. It has decreased from 69.82 (Mar 24) to 66.98, marking a decrease of 2.84.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 11.68. This value is within the healthy range. It has decreased from 12.37 (Mar 24) to 11.68, marking a decrease of 0.69.
- For PBIT / Share (Rs.), as of Mar 25, the value is 9.96. This value is within the healthy range. It has decreased from 10.49 (Mar 24) to 9.96, marking a decrease of 0.53.
- For PBT / Share (Rs.), as of Mar 25, the value is 16.22. This value is within the healthy range. It has increased from 9.90 (Mar 24) to 16.22, marking an increase of 6.32.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 12.29. This value is within the healthy range. It has increased from 7.04 (Mar 24) to 12.29, marking an increase of 5.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 12.94. This value is within the healthy range. It has increased from 7.66 (Mar 24) to 12.94, marking an increase of 5.28.
- For PBDIT Margin (%), as of Mar 25, the value is 17.44. This value is within the healthy range. It has decreased from 17.71 (Mar 24) to 17.44, marking a decrease of 0.27.
- For PBIT Margin (%), as of Mar 25, the value is 14.86. This value is within the healthy range. It has decreased from 15.02 (Mar 24) to 14.86, marking a decrease of 0.16.
- For PBT Margin (%), as of Mar 25, the value is 24.21. This value is within the healthy range. It has increased from 14.18 (Mar 24) to 24.21, marking an increase of 10.03.
- For Net Profit Margin (%), as of Mar 25, the value is 18.34. This value exceeds the healthy maximum of 10. It has increased from 10.08 (Mar 24) to 18.34, marking an increase of 8.26.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 19.31. This value is within the healthy range. It has increased from 10.96 (Mar 24) to 19.31, marking an increase of 8.35.
- For Return on Networth / Equity (%), as of Mar 25, the value is 13.12. This value is below the healthy minimum of 15. It has increased from 8.40 (Mar 24) to 13.12, marking an increase of 4.72.
- For Return on Capital Employeed (%), as of Mar 25, the value is 9.61. This value is below the healthy minimum of 10. It has decreased from 10.89 (Mar 24) to 9.61, marking a decrease of 1.28.
- For Return On Assets (%), as of Mar 25, the value is 10.83. This value is within the healthy range. It has increased from 6.71 (Mar 24) to 10.83, marking an increase of 4.12.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.57. It has decreased from 0.64 (Mar 24) to 0.57, marking a decrease of 0.07.
- For Current Ratio (X), as of Mar 25, the value is 3.56. This value exceeds the healthy maximum of 3. It has increased from 2.90 (Mar 24) to 3.56, marking an increase of 0.66.
- For Quick Ratio (X), as of Mar 25, the value is 2.75. This value exceeds the healthy maximum of 2. It has increased from 2.24 (Mar 24) to 2.75, marking an increase of 0.51.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 5.48. This value is within the healthy range. It has increased from 3.92 (Mar 24) to 5.48, marking an increase of 1.56.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 19.32. This value is below the healthy minimum of 20. It has decreased from 19.58 (Mar 24) to 19.32, marking a decrease of 0.26.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 17.05. This value is below the healthy minimum of 20. It has increased from 15.73 (Mar 24) to 17.05, marking an increase of 1.32.
- For Earning Retention Ratio (%), as of Mar 25, the value is 80.68. This value exceeds the healthy maximum of 70. It has increased from 80.42 (Mar 24) to 80.68, marking an increase of 0.26.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 82.95. This value exceeds the healthy maximum of 70. It has decreased from 84.27 (Mar 24) to 82.95, marking a decrease of 1.32.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 24.37. This value is within the healthy range. It has increased from 20.98 (Mar 24) to 24.37, marking an increase of 3.39.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 12.57. This value is within the healthy range. It has decreased from 12.94 (Mar 24) to 12.57, marking a decrease of 0.37.
- For Enterprise Value (Cr.), as of Mar 25, the value is 11,222.93. It has decreased from 15,601.90 (Mar 24) to 11,222.93, marking a decrease of 4,378.97.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 2.71. This value is within the healthy range. It has decreased from 3.61 (Mar 24) to 2.71, marking a decrease of 0.90.
- For EV / EBITDA (X), as of Mar 25, the value is 15.53. This value exceeds the healthy maximum of 15. It has decreased from 20.40 (Mar 24) to 15.53, marking a decrease of 4.87.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.53 (Mar 24) to 2.69, marking a decrease of 0.84.
- For Retention Ratios (%), as of Mar 25, the value is 80.67. This value exceeds the healthy maximum of 70. It has increased from 80.41 (Mar 24) to 80.67, marking an increase of 0.26.
- For Price / BV (X), as of Mar 25, the value is 1.83. This value is within the healthy range. It has decreased from 2.71 (Mar 24) to 1.83, marking a decrease of 0.88.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 2.69. This value is within the healthy range. It has decreased from 3.53 (Mar 24) to 2.69, marking a decrease of 0.84.
- For EarningsYield, as of Mar 25, the value is 0.07. This value is below the healthy minimum of 5. It has increased from 0.03 (Mar 24) to 0.07, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Finolex Industries Ltd:
- Net Profit Margin: 18.34%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 9.61% (Industry Average ROCE: 8.77%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 13.12% (Industry Average ROE: 6.76%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 12.57
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 2.75
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 24.6 (Industry average Stock P/E: 24.6)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.03
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 18.34%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Plastics - Pipes & Fittings | Gat No. 399, Village Urse, Pune District Maharashtra 410506 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Prakash P Chhabria | Executive Chairman |
| Mr. Saurabh S Dhanorkar | Managing Director |
| Mr. Saumya Chakrabarti | Director - Technical |
| Mrs. Ritu P Chhabria | Non Exe.Non Ind.Director |
| Mrs. Kanchan U Chitale | Independent Director |
| Mr. Debabrata Sarkar | Independent Director |
| Mr. Vijay Bhatt | Independent Director |
| Mr. Aditya Sapru | Independent Director |
| Mr. Munesh Khanna | Independent Director |
| Mr. Pradeep Udhas | Independent Director |
| Mr. Rajesh Rathi | Independent Director |
FAQ
What is the intrinsic value of Finolex Industries Ltd?
Finolex Industries Ltd's intrinsic value (as of 15 February 2026) is ₹105.19 which is 44.34% lower the current market price of ₹189.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹11,710 Cr. market cap, FY2025-2026 high/low of ₹238/144, reserves of ₹5,666 Cr, and liabilities of ₹6,609 Cr.
What is the Market Cap of Finolex Industries Ltd?
The Market Cap of Finolex Industries Ltd is 11,710 Cr..
What is the current Stock Price of Finolex Industries Ltd as on 15 February 2026?
The current stock price of Finolex Industries Ltd as on 15 February 2026 is ₹189.
What is the High / Low of Finolex Industries Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Finolex Industries Ltd stocks is ₹238/144.
What is the Stock P/E of Finolex Industries Ltd?
The Stock P/E of Finolex Industries Ltd is 24.6.
What is the Book Value of Finolex Industries Ltd?
The Book Value of Finolex Industries Ltd is 93.3.
What is the Dividend Yield of Finolex Industries Ltd?
The Dividend Yield of Finolex Industries Ltd is 1.06 %.
What is the ROCE of Finolex Industries Ltd?
The ROCE of Finolex Industries Ltd is 8.77 %.
What is the ROE of Finolex Industries Ltd?
The ROE of Finolex Industries Ltd is 6.76 %.
What is the Face Value of Finolex Industries Ltd?
The Face Value of Finolex Industries Ltd is 2.00.